Biocomposites SRL will support sales of STIMULAN, NanoBone, genex and SYNICEM Spacers throughout Italy New team has been hired and first sales have already taken place Keele, UK, 16 January 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue, is pleased […]
New record for sales growth and number of patients supported Product portfolio enhanced through acquisition of NanoBone® and expansion of STIMULAN® approval as an antibiotic carrier to treat bacterial infection Research and Development boosts with STIMULAN VG moving to phase II clinical trial and investment in Renovite Keele, UK, 13 December 2023 – Biocomposites, an international […]
SYNICEM™ hip, knee and shoulder spacers are preformed and loaded with gentamicin to maintain space and aid treatment of infection Already successfully used in UK patients as part of their infection treatment strategies Keele, UK, 21 November 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in […]
Winner of two Queen’s Awards for Enterprise in Innovation and International Trade Highest year-on-year sales growth in the company’s 25-year history Keele, UK, 14 December 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary […]
Consensus group of clinicians have developed a framework of best practice and toolkit for podiatrists treating diabetic foot infections STIMULAN placed in foot wounds following debridement can release antibiotics at therapeutic concentrations Keele, UK, 3 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in […]
